Skip to main content
. 2020 Feb 11;11:44. doi: 10.3389/fphar.2020.00044

Table 2.

The incidence of CI-AKI and the length of hospital stay in the amlodipine and control group.

Outcome Amlodipine group (n=868) Control group (n=1,798) Matched control group (n=868) P1 P2
CI-AKI 69 (7.95%) 211 (11.74%) 103 (11.87%) 0.003 0.006
Hospital stay 7.08 ± 7.28 7.77 ± 7.82 7.81 ± 7.58 0.027 0.040

CI-AKI, contrast-induced acute kidney injury; P1, Amlodipine group vs Control group; P2, Amlodipine group vs Matched control group.